Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan flag Jordan · Delayed Price · Currency is JOD
2.000
+0.010 (0.50%)
At close: Jul 30, 2026

ASE:PHIL Financials Overview

Millions JOD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
8.979.178.768.48.426.6
Revenue Growth
-2.34%4.64%4.25%-0.12%27.48%-13.77%
Gross Profit
4.444.514.1243.913.13
Operating Income
1.521.541.41.351.10.72
Net Income
1.061.010.820.810.70.41
Earnings Per Share
0.140.130.110.110.090.05
EPS Growth
15.93%22.35%1.77%15.13%70.91%189.49%

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Jordan
4.744.7743.493.352.9
Export
4.234.44.764.915.063.71
Total
8.979.178.768.48.426.6

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.841.831.651.41.51.66
Total Debt
2.641.761.991.491.831.45
Net Cash (Debt)
-0.80.07-0.33-0.09-0.330.21
Net Cash Growth
------
Net Cash Per Share
-0.110.01-0.04-0.01-0.040.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1.141.371.721.12.113.15
Capital Expenditures
-0.25-0.21-0.19-0.07-0.17-0.2
Free Cash Flow
0.881.161.531.031.942.94
Free Cash Flow Growth
-61.56%-24.16%47.69%-46.74%-34.02%88.22%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
49.48%49.16%47.03%47.64%46.42%47.47%
Operating Margin
16.97%16.77%15.94%16.12%13.05%10.90%
Pretax Margin
13.69%13.88%11.87%12.16%10.29%7.48%
Profit Margin
11.82%10.96%9.38%9.60%8.33%6.21%
FCF Margin
9.85%12.63%17.43%12.30%23.07%44.57%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.070-0.0700.0700.0600.060
Dividend Per Share Growth
0%-0%16.67%0%-
Dividend Yield
3.50%-5.12%5.63%5.19%5.51%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.1511.9413.6913.2914.8725.05
P/FCF Ratio
16.9710.367.3710.375.373.49
PS Ratio
1.671.311.281.281.241.56